Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23418)

• Formulation Name: Delafloxacin Meglumine 450 mg tablet
• Company: Melinta Therapeutics

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
ABT-492	(DMJFD2I)	Bacterial infection	1A00-1C4Z	Phase 3

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Betadex sulfobutyl ether sodium	(E00589)	66577045	Solubilizing agent
Edetate disodium	(E00186)	8759	Complexing agent
Meglumine	(E00181)	8567	Buffering agent